Skip to Content

Workers’ Compensation Board

Search menu

Due to the eCase problems this morning, the NYS ITS team performed emergency maintenance to restore service. eCase is now available again. If you are still logged into eCase, please log out and close your browser(s), then log back into eCase. We apologize for the inconvenience.

Subject Number 046-1193 Temporary Suspension of Dr. Stuart Chale

Subject Numbers Regarding Health Provider Authorizations

Authorization No. 177417-3W

July 30, 2019

Pursuant to Workers' Compensation Law (WCL) § 13-d(4), the Chair of the New York State Workers' Compensation Board has exercised her authority to temporarily suspend Dr. Stuart Chale's authorization to treat injured workers in the New York State workers' compensation system effective July 29, 2019. Dr. Singh's last known business address is:

101 Nicholls Road, HSC Level 4 Room 080
Stony Brook, New York 11794

The Chair's designee's investigation has revealed that, despite multiple written requests, Dr. Chale has failed and refused to provide the Board with proof of reimbursement of the sum of $715.40 to claimant's private health insurer, which sum having also been paid to Dr. Chale by the claimant's workers' compensation carrier for the same treatment.

As a result of the foregoing, the Chair believes that Dr. Chale may be guilty of misconduct under WCL §13-d(2)(f) for the refusal to produce "any relevant book or paper concerning his or her conduct under any authorization granted to him or her under this chapter."

Dr. Chale is prohibited from rendering treatment and care to injured workers and from conducting reviews of records regarding variance requests pursuant to 12 NYCRR § 324.3(b)(2)(ii)(a) while his authorization is temporarily suspended. Reports submitted by Dr. Chale for services rendered prior to July 29, 2019, are valid, but are invalid for any services rendered on or after that date. Requests to cross-examine Dr. Chale for services rendered prior to July 29, 2019, should not be denied due to the suspension of his authorization.

This suspension remains in effect until further notice. Any questions regarding the authorized lists should be referred to the Medical Director's Office at 1 (800) 781-2362.

Clarissa M. Rodriguez
Chair